• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[哈贝卡星与其他4种氨基糖苷类药物对革兰氏阴性杆菌的比较活性。耐药性的演变]

[Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].

作者信息

Reynaud A E, Coude du Foresto B, Derriennic M, Courtieu A L

机构信息

Laboratoire de Bactériologie A, Hôtel-Dieu, CHR, Nantes.

出版信息

Pathol Biol (Paris). 1988 May;36(5):435-8.

PMID:3136424
Abstract

The activity of 5 aminoglycosides compounds (habekacin, amikacin, gentamicin, netilmicin and tobramycin) was studied by an agar dilution method, against 235 strains of Enterobacteriaceae and 146 other Gram negative bacilli. 79 to 98% of susceptible strains were observed, according to the aminoglycoside compound. Habekacin and amikacin were the most effective, specially against the more frequently resistant bacteria: Enterobacter, Serratia, Hafnia, Acinetobacter, Pseudomonas aeruginosa. In comparison with a previous study, no evolution was observed in the resistance to aminoglycosides.

摘要

采用琼脂稀释法研究了5种氨基糖苷类化合物(哈贝卡星、阿米卡星、庆大霉素、奈替米星和妥布霉素)对235株肠杆菌科细菌和146株其他革兰氏阴性杆菌的活性。根据氨基糖苷类化合物的不同,观察到79%至98%的敏感菌株。哈贝卡星和阿米卡星最有效,尤其对更常见的耐药菌:肠杆菌属、沙雷菌属、哈夫尼菌属、不动杆菌属、铜绿假单胞菌。与之前的研究相比,未观察到对氨基糖苷类药物耐药性的变化。

相似文献

1
[Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].[哈贝卡星与其他4种氨基糖苷类药物对革兰氏阴性杆菌的比较活性。耐药性的演变]
Pathol Biol (Paris). 1988 May;36(5):435-8.
2
In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.奈替米星、庆大霉素、妥布霉素和阿米卡星对葡萄糖发酵菌和非发酵菌的体外活性。
Chemotherapy. 1980;26(5):323-33. doi: 10.1159/000237924.
3
Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.铜绿假单胞菌和肠道革兰氏阴性杆菌的当前临床分离株对阿米卡星和其他氨基糖苷类抗生素的敏感性。
J Infect Dis. 1976 Nov;134 SUPPL:S394-90.
4
Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.汇编了关于氨基糖苷类的数据,主要是细菌菌株对奈替米星的敏感性。
Scand J Infect Dis Suppl. 1980;Suppl 23:39-44.
5
A laboratory assessment of the activities of four aminoglycosides.四种氨基糖苷类药物活性的实验室评估
S Afr Med J. 1984 Jun 9;65(23):922-4.
6
In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.庆大霉素和/或妥布霉素耐药革兰氏阴性杆菌对七种氨基糖苷类药物的体外敏感性
Infection. 1978;6(3):111-5. doi: 10.1007/BF01642258.
7
In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.耐庆大霉素肠杆菌科细菌和铜绿假单胞菌对氨基糖苷类抗生素的体外敏感性
Bol Asoc Med P R. 1983 Jul;75(7):305-7.
8
Invitro comparative evaluation of aminoglycosides at a cancer centre.癌症中心氨基糖苷类药物的体外比较评估
Indian J Cancer. 2002 Oct-Dec;39(4):135-8.
9
Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.西索米星、奈替米星和地贝卡星。对其抗菌活性和治疗用途的综述。
Drugs. 1984 Jun;27(6):548-78. doi: 10.2165/00003495-198427060-00003.
10
Interaction of gentamicin, dibekacin, netilmicin and amikacin with various penicillins, cephalosporins, minocycline and new fluoro-quinolones against Enterobacteriaceae and Pseudomonas aeruginosa.
J Antimicrob Chemother. 1985 Nov;16(5):581-7. doi: 10.1093/jac/16.5.581.

引用本文的文献

1
Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.奈替米星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1989 Nov;38(5):703-56. doi: 10.2165/00003495-198938050-00003.